SAM
BIIB icon

Symphony Asset Management’s Biogen BIIB Stock Holding History

Symphony Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-6,251
Closed -$1.71M – 193
2018
Q2 		$1.71M Sell
6,251
-1,009
-14% -$284K 0.34% 64
2018
Q1 		$1.99M Sell
7,260
-3,237
-31% -$1M 0.26% 94
2017
Q4 		$3.34M Sell
10,497
-44
-0.4% -$14.1K 0.34% 69
2017
Q3 		$3.3M Sell
10,541
-504
-5% -$149K 0.37% 67
2017
Q2 		$3M Buy
11,045
+5,271
+91% +$1.39M 0.34% 72
2017
Q1 		$1.58M Buy
5,774
+212
+4% +$59.9K 0.15% 148
2016
Q4 		$1.58M Buy
5,562
+403
+8% +$119K 0.16% 141
2016
Q3 		$1.61M Sell
5,159
-275
-5% -$81.4K 0.16% 144
2016
Q2 		$1.31M Sell
5,434
-770
-12% -$203K 0.14% 157
2016
Q1 		$1.61M Buy
6,204
+1,543
+33% +$408K 0.17% 137
2015
Q4 		$1.43M Sell
4,661
-83
-2% -$23.9K 0.16% 150
2015
Q3 		$1.38M Sell
4,744
-1,028
-18% -$339K 0.17% 144
2015
Q2 		$2.33M Buy
5,772
+976
+20% +$392K 0.29% 90
2015
Q1 		$2.02M Sell
4,796
-547
-10% -$216K 0.24% 99
2014
Q4 		$1.81M Sell
5,343
-1,048
-16% -$339K 0.23% 110
2014
Q3 		$2.12M Sell
6,391
-3,548
-36% -$1.17M 0.22% 96
2014
Q2 		$3.13M Sell
9,939
-1,449
-13% -$436K 0.33% 88
2014
Q1 		$3.48M Buy
11,388
+2,541
+29% +$807K 0.33% 80
2013
Q4 		$2.47M Buy
8,847
+1,447
+20% +$374K 0.18% 115
2013
Q3 		$1.78M Buy
7,400
+412
+6% +$92.2K 0.18% 127
2013
Q2 		$1.5M Buy
+6,988
New +$1.49M 0.14% 140

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Symphony Asset Management's BIIB Position: Q3 2018 in Review

Symphony Asset Management sold out of Biogen (BIIB) in Q3 2018, closing a stake of 6,251 shares — an estimated $1.71M sold.

Symphony Asset Management first reported a position in BIIB in Q2 2013 and held it in 21 quarters. The position peaked at $3.48M in Q1 2014. 1,146 funds tracked by Wall St. Rank hold BIIB as of Q3 2018.

  • Symphony Asset Management reported no remaining Biogen position as of Q3 2018 after selling out during the quarter.
  • Symphony Asset Management sold 6,251 Biogen shares in Q3 2018, an estimated $1.71M.
  • Symphony Asset Management first reported a position in Biogen in Q2 2013 and held it in 21 quarters.
  • Symphony Asset Management's Biogen position peaked at $3.48M in Q1 2014.
  • 1,146 funds tracked by Wall St. Rank held Biogen as of Q3 2018.

Based on Symphony Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.